Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

THE STUDY OF APOPTOSIS MECHANISM IN THE PROCESS OF RECOMBINANT INTERLEUKIN-12 TREAT THE MICE WITH VIRAL MYOCARDITIS

View through CrossRef
Objectives Through studying the NK cell activity, the pathological changes of myocardial cells and the changes of apoptosis in the process of recombinant interleukin -12 treat the mice with viral myocarditis, to explore the therapeutic effect and mechanism of apoptosis in the process of recombinant interleukin -12 treat the viral diseases, to further reveal the treatment effect and therapeutic mechanism of recombinant interleukin-12 to viral diseases, and to make a theoretical foundation for the clinical use of recombinant interleukin -12. Methods A total of 90 BALB/C inbreeding male mice weight 14–18 g were randomly divided into six groups, each group has 15 mice. They are blank control group, the virus control group, drug control group, rmIL-12 small dose treatment group, medium dose treatment group, high dose treatment group. Each mouse was injected Coxsackie B3 0.2 ml/d for three consecutive days by intraperitoneal injection, in addition to except the mouse in blank control group. After inoculating 4 h, in the blank control group and the virus control group, each mouse was inoculated 0.9% saline 0.1 ml / d by intraperitoneal injection, in the drug control group, each mouse was inoculated interferon-of γ 400 IU/d, rmIL-12 small-dose, medium-dose and high-dose treatment group, the mouse in each group were injected recombinant interleukin-12 respectively 1 ng/d, 10 ng/d, 100 ng/d for five consecutive days. The time of injecting virus is the zeroth day. At the fifth day, we take 10 mice from each group, than killed them by cervical dislocation. We removed the spleens for testing the NK cell activity, under sterile conditions. We removed the hearts, than make heart specimens. We soaked the heart in 10% formalin solution and marked them for the test of heart pathology and apoptosis. NK cell activity was measured by MTT assay. Apoptosis was detected by TUNEL and pathological scores. Cardiac muscle pathology was detected by HE staining. The statistical data was expressed as mean±SD (□±S), The data were analysed by SPSS17.0 statistical software analysis system. Groups were analysed using analysis of variance. p<0.05 was considered as statistically significant. Results In addition to the blank control group, each group can be detected the apoptosis of myocardial cells. The pathological scores of apoptotic cells are that, high dose treatment group is 29.18%, medium dose treatment group is 20.97%, small dose treatment group is 12.03%, drug control group is 10.51%, virus control group is 15.63%. The largest number of apoptotic cells is the high dose treatment group, followed by the middle dose treatment group, and the low dose treatment group and the virus control group is less than the above two groups. The NK cell activity in each group is that, blank control group is 29.58±4.56%, virus control group is 46.99±6.31%, drug control group is 34.54±3.98%, small dose treatment group is 42.14±4.02%, medium dose treatment group is 54.55±7.17%, high dose treatment group 57.06±4.55%. There are statistically significant differences in different groups about NK cell activity, F=34.98, p<0.01. There are significant differences in medium-dose group, virus control group and the drug control group p<0.05). There are not significant differences between drug control group and small dose treatment group. Myocardial pathological changes (the degeneration and necrosisis of myocardial cell) are lighter in medium-dose treatment group than the other treatment groups. And, the virus control group and the high dose treatment group are most severe than other groups. The blank control group has not the degeneration and necrosisis. Conclusions In middle-dose treatment group, the number of myocardial cell degeneration and necrosis is least, indicating recombinant interleukin −12 have therapeutic action to viral myocarditis. The number of apoptotic myocardial cells increased with therapeutic dose of recombinant interleukin −12, and moderate apoptosis have an active role to clear virus-infected cells. Which indicating apoptosis is one of the treatment mechanism of recombinant interleukin-12.
Title: THE STUDY OF APOPTOSIS MECHANISM IN THE PROCESS OF RECOMBINANT INTERLEUKIN-12 TREAT THE MICE WITH VIRAL MYOCARDITIS
Description:
Objectives Through studying the NK cell activity, the pathological changes of myocardial cells and the changes of apoptosis in the process of recombinant interleukin -12 treat the mice with viral myocarditis, to explore the therapeutic effect and mechanism of apoptosis in the process of recombinant interleukin -12 treat the viral diseases, to further reveal the treatment effect and therapeutic mechanism of recombinant interleukin-12 to viral diseases, and to make a theoretical foundation for the clinical use of recombinant interleukin -12.
Methods A total of 90 BALB/C inbreeding male mice weight 14–18 g were randomly divided into six groups, each group has 15 mice.
They are blank control group, the virus control group, drug control group, rmIL-12 small dose treatment group, medium dose treatment group, high dose treatment group.
Each mouse was injected Coxsackie B3 0.
2 ml/d for three consecutive days by intraperitoneal injection, in addition to except the mouse in blank control group.
After inoculating 4 h, in the blank control group and the virus control group, each mouse was inoculated 0.
9% saline 0.
1 ml / d by intraperitoneal injection, in the drug control group, each mouse was inoculated interferon-of γ 400 IU/d, rmIL-12 small-dose, medium-dose and high-dose treatment group, the mouse in each group were injected recombinant interleukin-12 respectively 1 ng/d, 10 ng/d, 100 ng/d for five consecutive days.
The time of injecting virus is the zeroth day.
At the fifth day, we take 10 mice from each group, than killed them by cervical dislocation.
We removed the spleens for testing the NK cell activity, under sterile conditions.
We removed the hearts, than make heart specimens.
We soaked the heart in 10% formalin solution and marked them for the test of heart pathology and apoptosis.
NK cell activity was measured by MTT assay.
Apoptosis was detected by TUNEL and pathological scores.
Cardiac muscle pathology was detected by HE staining.
The statistical data was expressed as mean±SD (□±S), The data were analysed by SPSS17.
0 statistical software analysis system.
Groups were analysed using analysis of variance.
p<0.
05 was considered as statistically significant.
Results In addition to the blank control group, each group can be detected the apoptosis of myocardial cells.
The pathological scores of apoptotic cells are that, high dose treatment group is 29.
18%, medium dose treatment group is 20.
97%, small dose treatment group is 12.
03%, drug control group is 10.
51%, virus control group is 15.
63%.
The largest number of apoptotic cells is the high dose treatment group, followed by the middle dose treatment group, and the low dose treatment group and the virus control group is less than the above two groups.
The NK cell activity in each group is that, blank control group is 29.
58±4.
56%, virus control group is 46.
99±6.
31%, drug control group is 34.
54±3.
98%, small dose treatment group is 42.
14±4.
02%, medium dose treatment group is 54.
55±7.
17%, high dose treatment group 57.
06±4.
55%.
There are statistically significant differences in different groups about NK cell activity, F=34.
98, p<0.
01.
There are significant differences in medium-dose group, virus control group and the drug control group p<0.
05).
There are not significant differences between drug control group and small dose treatment group.
Myocardial pathological changes (the degeneration and necrosisis of myocardial cell) are lighter in medium-dose treatment group than the other treatment groups.
And, the virus control group and the high dose treatment group are most severe than other groups.
The blank control group has not the degeneration and necrosisis.
Conclusions In middle-dose treatment group, the number of myocardial cell degeneration and necrosis is least, indicating recombinant interleukin −12 have therapeutic action to viral myocarditis.
The number of apoptotic myocardial cells increased with therapeutic dose of recombinant interleukin −12, and moderate apoptosis have an active role to clear virus-infected cells.
Which indicating apoptosis is one of the treatment mechanism of recombinant interleukin-12.

Related Results

Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Immune checkpoint inhibitor-associated myocarditis: diagnostic challenges
Abstract Background Immune checkpoint inhibitors (ICIs), which are increasingly used in cancer pharmacotherapy, can induce myoca...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
Abstract Background Myocarditis is a recognized complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...
Exercise testing in patients with multisystem inflammatory syndrome in children-related myocarditis versus idiopathic or viral myocarditis
Exercise testing in patients with multisystem inflammatory syndrome in children-related myocarditis versus idiopathic or viral myocarditis
AbstractBackground:While most children with multisystem inflammatory syndrome in children have rapid recovery of cardiac dysfunction, little is known about the long-term outcomes r...
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Background: Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency...
P1813Impact of cardiac MRI imaging on detection rates of myocarditis
P1813Impact of cardiac MRI imaging on detection rates of myocarditis
Abstract Background The Lake Louise Criteria for the diagnosis of myocarditis by cardiac MRI (CMR) was published in 2009 (JACC A...
The immunomodulatory effects of exercise in viral and vaccine-associated myocarditis
The immunomodulatory effects of exercise in viral and vaccine-associated myocarditis
Approximately five years ago, under the guidance of my supervisors, our research group initiated a series of experimental studies using the murine coxsackievirus B3 model to invest...

Back to Top